πŸ‡ΊπŸ‡Έ FDA
Patent

US 12077612

Peptide compositions

granted A61KA61K38/00A61K38/12

Quick answer

US patent 12077612 (Peptide compositions) held by RHYTHM PHARMACEUTICALS, INC. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RHYTHM PHARMACEUTICALS, INC.
Grant date
Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61K38/12, A61P, A61P1/16